Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents
Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents have?
Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents has 429 citations in the OpenAlex counts ScholarIQ stores.
When was Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents published?
Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents has 2010 year in the ScholarIQ index.
What is the open-access status of Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents?
Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents has gold oa status in the ScholarIQ index.
What is the DOI of Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents?
The DOI for Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents is on the source record.
What is the PMID of Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents?
The PMID for Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents is on the source record.
What is the OpenAlex record for Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents?
The OpenAlex for Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents is on the source record.